236 related articles for article (PubMed ID: 17381371)
1. Underutilization of evidence-based therapies in heart failure: the pharmacist's role.
Rodgers JE; Stough WG
Pharmacotherapy; 2007 Apr; 27(4 Pt 2):18S-28S. PubMed ID: 17381371
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic implications of new strategies for heart failure management in the managed care setting.
Chase SL; Pickworth KK
Pharmacotherapy; 2007 Apr; 27(4 Pt 2):29S-32S. PubMed ID: 17381372
[TBL] [Abstract][Full Text] [Related]
3. The new heart failure guidelines: strategies for implementation.
O'Connor CM
Am Heart J; 2007 Apr; 153(4 Suppl):2-5. PubMed ID: 17394896
[TBL] [Abstract][Full Text] [Related]
4. The impact of clinical pharmacists on drug-related problems and clinical outcomes.
Viktil KK; Blix HS
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):275-80. PubMed ID: 18248511
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary rounds (MDR): an implementation system for sustained improvement in the American Heart Association's Get With The Guidelines program.
Ellrodt G; Glasener R; Cadorette B; Kradel K; Bercury C; Ferrarin A; Jewell D; Frechette C; Seckler P; Reed J; Langou A; Surapaneni N;
Crit Pathw Cardiol; 2007 Sep; 6(3):106-16. PubMed ID: 17804970
[TBL] [Abstract][Full Text] [Related]
6. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; Mehra M; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2007 Jul; 154(1):12-38. PubMed ID: 17584548
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review.
Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M
J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336
[TBL] [Abstract][Full Text] [Related]
8. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
[TBL] [Abstract][Full Text] [Related]
9. Current guidelines for treatment of heart failure: 2006 update.
Uddin N; Patterson JH
Pharmacotherapy; 2007 Apr; 27(4 Pt 2):12S-17S. PubMed ID: 17381370
[TBL] [Abstract][Full Text] [Related]
10. Role of a pharmacist in improving rational drug therapy as part of the patient care team.
Smith WE
Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008
[TBL] [Abstract][Full Text] [Related]
11. Managed care interventions for improving outcomes in acute heart failure syndromes.
Khan SS; Gheorghiade M; Dunn JD; Pezalla E; Fonarow GC
Am J Manag Care; 2008 Dec; 14(12 Suppl Managed):S273-86; quiz S287-91. PubMed ID: 19166273
[TBL] [Abstract][Full Text] [Related]
12. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
[TBL] [Abstract][Full Text] [Related]
13. Pharmacist roles in the management of patients with type 2 diabetes.
Sisson E; Kuhn C
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
[TBL] [Abstract][Full Text] [Related]
14. Management strategies to meet the core heart failure measures for acute decompensated heart failure: a nursing perspective.
Gardetto NJ; Carroll KC
Crit Care Nurs Q; 2007; 30(4):307-20. PubMed ID: 17873567
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
Bottorff MB; Nutescu EA; Spinler S
Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
[TBL] [Abstract][Full Text] [Related]
16. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
17. Cardiac rehabilitation coordinators' perceptions of patient-related barriers to implementing cardiac evidence-based guidelines.
Fernandez RS; Davidson P; Griffiths R
J Cardiovasc Nurs; 2008; 23(5):449-57. PubMed ID: 18728518
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
Kjeldby C; Bjerre A; Refsum N
Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
[TBL] [Abstract][Full Text] [Related]
19. Care transitions in elderly heart failure patients: current practices and the pharmacist's role.
Kitts NK; Reeve AR; Tsu L
Consult Pharm; 2014 Mar; 29(3):179-90. PubMed ID: 24589767
[TBL] [Abstract][Full Text] [Related]
20. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
